Companies
HQSan Francisco
Employees11-50
Funding$95.1M
1 active role
AI / MLFoundation Model ProviderB2B SaaSSeries A$10M-$50M
About
Atomic AI builds an AI-powered RNA drug discovery platform that fuses deep learning with in-house wet-lab assays to design RNA-targeted small molecules and RNA-based therapeutics. The platform, including ATOM-1, supports accelerated discovery for biotech and pharma researchers targeting RNA biology. Revenue is generated from its proprietary R&D platform and related services.
Active Roles
1Key Investors
Playground Global, 8VC, Greylock, Nat Friedman